Biogen (BIIB) Call Leaves Tons of Questions, Priority Review Voucher Comment is Negative - Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Biogen (BIIB) Call Leaves Tons of Questions, Priority Review Voucher Comment is Negative - Mizuho
July 22, 2020 7:10 AM EDT
Mizuho Securities analyst Salim Syed reiterated a Neutral rating and $316.00 price target on Biogen (NASDAQ: BIIB) after the company announced that its CFO, Jeff Capello, is leaving. The transition occurs at a strange time raising numerous questions.
The analyst stated "Capello's... More
July 22, 2020 6:52 AM EDT
Biogen (NASDAQ: BIIB) reported Q2 EPS of $10.26, $2.22 better than the analyst estimate of $8.04. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.44 billion.
GUIDANCE:
Biogen sees FY2020 EPS of $34.00-$36.00, versus the consensus of $32.96. Biogen sees... More
July 22, 2020 6:32 AM EDT
Biogen (Nasdaq: BIIB) announced today the appointment of Michael (Mike) McDonnell as Executive Vice President and Chief Financial Officer, effective August 15, 2020. McDonnell joins Biogen from IQVIA (NYSE: IQV), where he is Executive Vice President and Chief Financial Officer. At Biogen, McDonnell will lead the global finance function and operations, the Companys shared services center, information technology and investor relations groups. He will report directly to Biogens Chief Executive Officer Michel Vounatsos, and will be based in Cambridge, Massachusetts.
McDonnell brings an extensive background in... More
